For: |
Ierardi E, Losurdo G, Giorgio F, Iannone A, Principi M, Leo AD. Quinolone-based first, second and third-line therapies for |
---|---|
URL: | https://www.wjgnet.com/2220-3192/full/v4/i4/274.htm |
Number | Citing Articles |
1 |
Giuseppe Losurdo, Fulvio Salvatore D’Abramo, Mariapaola Piazzolla, Raffaella Rima, Antonio Continisio, Maria Pricci, Enzo Ierardi, Alfredo Di Leo. Second-line Therapy for Helicobacter Pylori Eradication: State of the Art. Mini-Reviews in Medicinal Chemistry 2022; 22(19): 2430 doi: 10.2174/1389557522666220325153832
|
2 |
Floriana Giorgio, Enzo Ierardi, Claudia Sorrentino, Mariabeatrice Principi, Michele Barone, Giuseppe Losurdo, Andrea Iannone, Antonio Giangaspero, Rosa Monno, Alfredo Di Leo. Helicobacter pylori DNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis. Scandinavian Journal of Gastroenterology 2016; 51(12): 1429 doi: 10.1080/00365521.2016.1216592
|
3 |
Nagham H. Kamal, Fatema R. Saber, Abeer Salama, Dalia M. N. Abouhussein, Soha Ismail, Hala M. El-Hefnawy, Meselhy R. Meselhy. Enhanced wound healing activity of naturally derived Lagenaria siceraria seed oil binary nanoethosomal gel: formulation, characterization, in vitro/in vivo efficiency. Future Journal of Pharmaceutical Sciences 2024; 10(1) doi: 10.1186/s43094-024-00678-2
|
4 |
Giuseppe Losurdo, Floriana Giorgio, Andrea Iannone, Mariabeatrice Principi, Michele Barone, Alfredo Di Leo, Enzo Ierardi. Role of concomitant therapy for <i>Helicobacter pylori</i> eradication: A technical note. World Journal of Gastroenterology 2016; 22(38): 8638-8640 doi: 10.3748/wjg.v22.i38.8638
|